Oncolytics Biotech Inc. (ONC.TO)

CAD 1.1

(-2.65%)

Total Debt Summary of Oncolytics Biotech Inc.

  • Oncolytics Biotech Inc.'s latest annual total debt in 2023 was 423 Thousand CAD , up 13.4% from previous year.
  • Oncolytics Biotech Inc.'s latest quarterly total debt in 2024 Q2 was 1.11 Million CAD , down -0.98% from previous quarter.
  • Oncolytics Biotech Inc. reported annual total debt of 373 Thousand CAD in 2022, down -43.03% from previous year.
  • Oncolytics Biotech Inc. reported annual total debt of 654.75 Thousand CAD in 2021, up 62.85% from previous year.
  • Oncolytics Biotech Inc. reported quarterly total debt of 1.11 Million CAD for 2024 Q2, down -0.98% from previous quarter.
  • Oncolytics Biotech Inc. reported quarterly total debt of 567 Thousand CAD for 2023 Q1, up 52.01% from previous quarter.

Annual Total Debt Chart of Oncolytics Biotech Inc. (2023 - 1999)

Historical Annual Total Debt of Oncolytics Biotech Inc. (2023 - 1999)

Year Total Debt Total Debt Growth
2023 423 Thousand CAD 13.4%
2022 373 Thousand CAD -43.03%
2021 654.75 Thousand CAD 62.85%
2020 402.05 Thousand CAD -20.58%
2019 506.27 Thousand CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2015 - CAD 0.0%
2014 - CAD 0.0%
2013 - CAD 0.0%
2012 - CAD 0.0%
2011 - CAD 0.0%
2010 - CAD 0.0%
2009 - CAD 0.0%
2008 - CAD 0.0%
2007 - CAD -100.0%
2006 150 Thousand CAD 0.0%
2005 150 Thousand CAD 0.0%
2004 150 Thousand CAD 0.0%
2003 150 Thousand CAD 0.0%
2002 150 Thousand CAD 0.0%
2001 150 Thousand CAD 0.0%
2000 150 Thousand CAD 0.0%
1999 150 Thousand CAD 0.0%

Peer Total Debt Comparison of Oncolytics Biotech Inc.

Name Total Debt Total Debt Difference
Appili Therapeutics Inc. 8.18 Million CAD 94.832%
Eupraxia Pharmaceuticals Inc. 13.78 Million CAD 96.931%
Helix BioPharma Corp. - CAD -Infinity%
Microbix Biosystems Inc. 6.64 Million CAD 93.635%
Medicenna Therapeutics Corp. - CAD -Infinity%
Satellos Bioscience Inc. - CAD -Infinity%
Sernova Corp. 136.12 Thousand CAD -210.748%